In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with ...
Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
Financing includes participation from leading institutional investors including Janus Henderson Investors, Brahma Capital, Biotrack Capital, Cormorant Asset Management, OrbiMed, Plaisance Capital ...
Exceptional performers drive innovation and help solve humanity's most pressing problems. Societies have a vital interest in the development of top performers in various fields. A recent review in the ...
Tuko News on MSN
Computer Science Graduate Shares How She Earned First-Class Honours, Became Valedictorian
Chine-me Rueben Esor, a computer science graduate, earned first-class honours and was recognised as the best student. She ...
OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral ...
Sample Question Papers 2026 for Science, Commerce, and Arts. Use these TN 11th board model papers to practice, assess your ...
The nation’s best and brightest have aced their senior school certificates, with the year 12 graduating class of 2025 now ...
Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...
Some patients dropped out of the trial early because they had lost so much weight.
The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours for 10 mg, 30 mg, 100 mg, 200 mg, 400 mg, and 600 mg, respectively, supporting once-daily or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback